Background

Problem Food Claims: LiveSpo International JSC t/a LiveSpo Colon UK breaks the UK advertising rules for claims that the LiveSpo Colon probiotic food supplement can prevent, treat or cure human disease.

The CAP Code states that claims which state or imply that a food supplement could prevent, treat or cure human disease break rule 15.6.2 of the Code. The definition of “disease” is wide in scope and includes any adverse condition, including claims that would be considered medicinal claims if they were made about a non-food product.

The www.livespo-colon.co.uk website makes a number of claims that the LiveSpo Colon probiotic food supplement can help treat a range of health conditions, symptoms and diseases. These include references that the supplements can help to treat: Leaky Gut, IBS, IBD, SIBO, C-Diff, Diverticulosis, Crohn’s Disease, Ulcerative Colitis, Diarrhoea, Abdominal pain and Bloating, amongst others.

The CAP Compliance team contacted LiveSpo International JSC and, in the absence of a response, took the decision on 27 January 2021 to place LiveSpo International JSC’s company details on this section of the ASA website. These details shall remain in place until such time as LiveSpo International JSC t/a LiveSpo Colon UK has appropriately amended the www.livespo-colon.co.uk website to ensure compliance with the CAP Code.

This entry was amended on 22 February 2021 to remove details of another website, which had been changed to delete claims to prevent, treat or cure human disease.


More on